AN2 Therapeutics, Inc.
ANTX

$31.93 M
Marketcap
$1.07
Share price
Country
$0.03
Change (1 day)
$22.22
Year High
$0.87
Year Low
Categories

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

marketcap

Stock price history for AN2 Therapeutics, Inc. (ANTX)

Highest end of day price: $22.29 USD on 2022-08-15

Lowest end of day price: $0.98 USD on 2024-08-16

Stock price history of AN2 Therapeutics, Inc. from 2022 to 2024